A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...

Prince William is set to undergo thorough cancer screenings after his former flight instructor died at age 47, allegedly from ...

Rick Patrick  rick@greenepublishing.com When Madison County resident Christopher Terry recently suffered a rib injury, it was ...

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

A decades-long Minneapolis firefighter is now fighting another battle of his own. Six months ago, Mark Lakosky was diagnosed ...

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

Films like Strong: Living with Multiple Myeloma are essential. Multiple Myeloma is not exactly high on the list of diseases ...

The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.

Ciltacabtagene autoleucel improved minimal residual disease negativity and sustained responses vs standard care in ...